Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4,17beta-dihydroxy-estr-4-en-3-one 17-cyclopentylpropionate
2. Oxabolone Cypionate
1. Oxabolone Cypionate
2. 1254-35-9
3. Oxabolone Cipioncate
4. Fi 5852
5. Oxabolone Cipionate [inn]
6. 5rxy50q01n
7. Oxabolone 17-cyclopentanepropionate
8. Nsc-522767
9. Fi-5852
10. Oxaboloni Cipionas
11. Esterbol Depo
12. Oxaboloni Cypionas
13. Ossabolone Cipionato
14. Cipionate D'oxabolone
15. Cipionato De Oxabolona
16. Unii-5rxy50q01n
17. Ossabolone Cipionato [dcit]
18. Oxaboloni Cipionas [inn-latin]
19. Ncgc00181156-01
20. Cipionate D'oxabolone [inn-french]
21. Einecs 215-011-8
22. Cipionato De Oxabolona [inn-spanish]
23. Dsstox_cid_26879
24. Dsstox_rid_81983
25. Dsstox_gsid_46879
26. [(8r,9s,10r,13s,14s,17s)-4-hydroxy-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate
27. Schembl4821339
28. Oxabolone Cipionate (jan/inn)
29. Chembl2105318
30. Dtxsid3046879
31. Chebi:31940
32. Oxabolone Cipionate [jan]
33. 4,17beta-dihydroxy-estr-4-en-3-one 17-cyclopentylpropionate
34. Oxabolone Cipionate [mart.]
35. Tox21_112760
36. Oxabolone Cipionate [who-dd]
37. Zinc26892649
38. Db13185
39. Nsc 522767
40. Cas-1254-35-9
41. 4-hydroxy-19-nortestosterone 17beta-cypionate
42. D01149
43. Oxabolone 17-cyclopentanepropionate [mi]
44. Q7115043
45. 4,17beta-dihydroxyestr-4-en-3-one 17-cyclopentanepropionate
46. 4,17.beta.-dihydroxyestr-4-en-3-one 17-cyclopentanepropionate
47. (8r,9s,13s,14s,17s)-4-hydroxy-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl 3-cyclopentylpropanoate
| Molecular Weight | 414.6 g/mol |
|---|---|
| Molecular Formula | C26H38O4 |
| XLogP3 | 5.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 5 |
| Exact Mass | 414.27700969 g/mol |
| Monoisotopic Mass | 414.27700969 g/mol |
| Topological Polar Surface Area | 63.6 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 733 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Used as a performance enhancing drug illicitly in athletes.
Androgenic effects include enhanced secondary sexual characteristics.
A - Alimentary tract and metabolism
A14 - Anabolic agents for systemic use
A14A - Anabolic steroids
A14AB - Estren derivatives
A14AB03 - Oxabolone cipionate
Route of Elimination
The metabolites and unchanged form of oxabolone can be detected in the urine.
Clearance
The elimination on the first day following intravenous injection of oxabolone cipionate is slow and reaches a rapid excretion phase with the maximum urinary level in the fifth day of administration.
The prodrug oxabolone cipionate is converted to oxabolone. Oxabolone is then metabolized into 4-Hydroxyestr-4-en-3,17-dione (M2) which is the most abundant metabolite via oxidation of the 17-hydroxyl group. 4-Hydroxyestran-3,17-dione (M1) is formed by reduction of the A ring double bond along with the oxidation of the 17-hydroxyl group. Three isomeric compounds exist as another metabolite, as the 3,4-dihydroxy-5-estran-17-one, 3,4-dihydroxy-5-estran-17-one, and 3,4-dihydroxy-5-estran-17-one.
ABOUT THIS PAGE
26
PharmaCompass offers a list of Oxabolone Cipionate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxabolone Cipionate manufacturer or Oxabolone Cipionate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxabolone Cipionate manufacturer or Oxabolone Cipionate supplier.
PharmaCompass also assists you with knowing the Oxabolone Cipionate API Price utilized in the formulation of products. Oxabolone Cipionate API Price is not always fixed or binding as the Oxabolone Cipionate Price is obtained through a variety of data sources. The Oxabolone Cipionate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A steranabol ritardo manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of steranabol ritardo, including repackagers and relabelers. The FDA regulates steranabol ritardo manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. steranabol ritardo API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A steranabol ritardo supplier is an individual or a company that provides steranabol ritardo active pharmaceutical ingredient (API) or steranabol ritardo finished formulations upon request. The steranabol ritardo suppliers may include steranabol ritardo API manufacturers, exporters, distributors and traders.
steranabol ritardo Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of steranabol ritardo GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right steranabol ritardo GMP manufacturer or steranabol ritardo GMP API supplier for your needs.
A steranabol ritardo CoA (Certificate of Analysis) is a formal document that attests to steranabol ritardo's compliance with steranabol ritardo specifications and serves as a tool for batch-level quality control.
steranabol ritardo CoA mostly includes findings from lab analyses of a specific batch. For each steranabol ritardo CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
steranabol ritardo may be tested according to a variety of international standards, such as European Pharmacopoeia (steranabol ritardo EP), steranabol ritardo JP (Japanese Pharmacopeia) and the US Pharmacopoeia (steranabol ritardo USP).
